| GI hormones and secretory products | 34 | May 7, 2012 |
| Hernias | 15 | May 6, 2012 |
| Endocrine | 71 | May 6, 2012 |
| Vasculitides | 13 | May 6, 2012 |
| Pathology | 16 | May 5, 2012 |
| Immune deficiencies | 14 | May 5, 2012 |
| Autoantibodies | 19 | May 5, 2012 |
| Immunology | 42 | May 5, 2012 |
| Lymphatic drainage | 12 | May 5, 2012 |
| Ego defenses | 20 | May 4, 2012 |
| Teratogens | 19 | May 4, 2012 |
| Embryology | 36 | May 4, 2012 |
| Behavioral | 54 | May 4, 2012 |
| Biochemistry (metabolism) | 88 | May 3, 2012 |
| Rate-determining enzymes of metabolic processes | 13 | May 3, 2012 |
| Biochemistry (genetics) | 20 | May 3, 2012 |
| Biochemistry (Molecular and Cellular) | 65 | May 3, 2012 |
| Musculoskeletal and connective tissue | 29 | May 2, 2012 |
| Heme/Onc | 60 | April 29, 2012 |
| Microbiology | 84 | April 27, 2012 |
| Treatments for psychiatric conditions | 16 | April 26, 2012 |
| Psych | 58 | April 26, 2012 |
| Neuro pathology | 7 | April 25, 2012 |
| Neuro physiology | 77 | April 24, 2012 |
| Reproductive | 28 | April 22, 2012 |
| Recombinant cytokines | 9 | April 21, 2012 |
| Therapeutic antibodies | 9 | April 21, 2012 |
| Immune deficiencies | 14 | April 21, 2012 |
| Cytokines | 13 | April 21, 2012 |
| Immunoglobulin isotypes | 5 | April 21, 2012 |
| CD Markers | 12 | April 21, 2012 |
| HLA-linked diseases | 8 | April 21, 2012 |
| GI pathology | 38 | April 19, 2012 |
| GI physiology | 27 | April 19, 2012 |
| Glomerular diseases | 11 | April 18, 2012 |
| Renal | 25 | April 18, 2012 |
| Respiratory pharmacology | 14 | April 16, 2012 |
| Respiratory | 35 | April 16, 2012 |
| Cardiovascular pharmacology | 28 | April 15, 2012 |
| Cardiovascular pathology | 69 | April 14, 2012 |
| Heart | 54 | April 13, 2012 |
| Embryology | 85 | April 12, 2012 |
| Drug reactions | 46 | April 12, 2012 |
| Antidotes for toxins | 22 | April 12, 2012 |
| Vitamins | 3 | April 12, 2012 |
| Autonomic drugs | 53 | April 11, 2012 |
| Paraneoplastic effects of tumors | 10 | April 11, 2012 |
| Chemical carcinogens | 9 | April 11, 2012 |
| Oncogenic microbes and disease conditions associated with neoplasms | 25 | April 11, 2012 |
| Tumor markers | 11 | April 11, 2012 |
| Oncogenes and tumor suppressor genes | 37 | April 11, 2012 |
| Drugs of Abuse | 31 | October 22, 2011 |
| Marijuana | 26 | October 22, 2011 |
| Anatomy: pharynx and larynx | 10 | October 16, 2011 |
| Anatomy: Intratemporal Fossa, Eye, Orbit | 15 | October 16, 2011 |
| Anatomy: face and parotid | 20 | October 16, 2011 |
| Anatomy: Muscles, Nerves, Arteries of Neck | 37 | October 15, 2011 |
| Anatomy: Bony landmarks | 39 | October 15, 2011 |
| Anatomy: Nasal Cavity and Pterygopalatine Fossa, Oral Cavity | 21 | October 11, 2011 |
| Anatomy: pharynx and larynx | 19 | October 11, 2011 |
| Anatomy: Orbit and Ear | 15 | October 11, 2011 |
| Glaucoma Drugs / Mydriatics | 34 | October 10, 2011 |
| Eye Movements | 17 | October 10, 2011 |
| BBB, CSF, Cerebral Circulation, Ischemic Injury | 31 | October 10, 2011 |